Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine

Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management

(2020) Kevin C.F. Fone et al.   MOLECULAR NEUROBIOLOGY

Serine Racemase Expression by Striatal Neurons

(2020) Shunsuke Takagi et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

The role of dopamine D3 receptors in the mechanism of action of cariprazine

(2019) Francesca Calabrese et al.   CNS SPECTRUMS

Blonanserin ameliorates social deficit through dopamine-D3 receptor antagonism in mice administered phencyclidine as an animal model of schizophrenia

(2019) Saori Takeuchi et al.   NEUROCHEMISTRY INTERNATIONAL

The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle

(2019) Samah Neame et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells

(2017) Rebecca L. Clarkson et al.   JOURNAL OF NEUROSCIENCE

Current drug treatments targeting dopamine D3 receptor

(2016) Gian Marco Leggio et al.   PHARMACOLOGY & THERAPEUTICS

Role for neonatal D-serine signaling: prevention of physiological and behavioral deficits in adult Pick1 knockout mice

(2015) J Nomura et al.   MOLECULAR PSYCHIATRY

Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment

(2014) Hidenaga Yamamori et al.   NEUROSCIENCE LETTERS

Reduced d-serine levels in the nucleus accumbens of cocaine-treated rats hinder the induction of NMDA receptor-dependent synaptic plasticity

(2013) Livia Curcio et al.   BRAIN

D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy

(2013) Silvia Sacchi et al.   CURRENT PHARMACEUTICAL DESIGN

Modulation of extracellular d-serine content by calcium permeable AMPA receptors in rat medial prefrontal cortex as revealed by in vivo microdialysis

(2013) Sayuri Ishiwata et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

(2013) Pierre Paoletti et al.   NATURE REVIEWS NEUROSCIENCE

Investigations into the involvement of NMDA mechanisms in recognition memory

(2013) E. Clea Warburton et al.   NEUROPHARMACOLOGY

Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors

(2013) L. Ladepeche et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction

(2013) D. T. Balu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Add-on Treatment of Benzoate for Schizophrenia

(2013) Hsien-Yuan Lane et al.   JAMA Psychiatry

Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes

(2012) Shunske Tanahashi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists

(2012) Thomas Papouin et al.   CELL

Dopaminergic Modulation of Synaptic Transmission in Cortex and Striatum

(2012) Nicolas X. Tritsch et al.   NEURON

Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control

(2011) Roshan Cools et al.   BIOLOGICAL PSYCHIATRY

Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex

(2011) Pascal Fossat et al.   CEREBRAL CORTEX

Simultaneous quantification of d- vs. l-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: Differential modulation by N-methyl-d-aspartate (NMDA) and other pharmacological agents

(2011) Alain Gobert et al.   JOURNAL OF NEUROSCIENCE METHODS

Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex

(2011) David JG Watson et al.   NEUROPSYCHOPHARMACOLOGY

The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures

(2010) Mark J. Millan et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex

(2010) T.-X. Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation

(2009) T.W. Robbins et al.   Annual Review of Neuroscience

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia

(2009) L Verrall et al.   MOLECULAR PSYCHIATRY

Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex

(2008) N. Santana et al.   CEREBRAL CORTEX

Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons

(2008) Can Gao et al.   JOURNAL OF NEUROCHEMISTRY

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior

(2008) A C Basu et al.   MOLECULAR PSYCHIATRY

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties

(2007) Tiziana Adage et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY